Hansoh Pharmaceutical Group Company Limited (HKG:3692)
35.44
-0.76 (-2.10%)
Sep 18, 2025, 1:45 PM HKT
HKG:3692 Revenue
Hansoh Pharmaceutical Group Company had revenue of 7.43B CNY in the half year ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 13.19B, up 9.02% year-over-year. In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B with 21.35% growth.
Revenue (ttm)
13.19B CNY
Revenue Growth
+9.02%
P/S Ratio
15.16
Revenue / Employee
1.47M CNY
Employees
8,989
Market Cap
219.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.26B | 2.16B | 21.35% |
Dec 31, 2023 | 10.10B | 721.40M | 7.69% |
Dec 31, 2022 | 9.38B | -552.73M | -5.56% |
Dec 31, 2021 | 9.94B | 1.24B | 14.33% |
Dec 31, 2020 | 8.69B | 7.49M | 0.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
CSPC Pharmaceutical Group | 28.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |